Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Prelude Therapeutics Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 60 | 56 | −4 |
| Shares | 36.6M | 34.7M | −1.89M (−5.2%) |
| Value | $113.1M | $148.3M | +$35.1M (+31.1%) |
New holders (6)
Institutions that held Prelude Therapeutics Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 4,133,000 | $17.6M | 0.33% |
| Jane Street Group, LLC | 32,977 | $140.8K | 0.00% |
| Amundi | 15,130 | $61.4K | 0.00% |
| Prelude Capital Management, LLC | 14,346 | $61.3K | 0.01% |
| Virtu Financial LLC | 13,607 | $58.0K | 0.00% |
| SG Americas Securities, LLC | 13,100 | $56.0K | 0.00% |
Sold out (10)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| EcoR1 Capital, LLC | 1,157,452 | $3.58M |
| Woodline Partners LP | 200,000 | $618.0K |
| Gsa Capital Partners LLP | 70,583 | $218.0K |
| D. E. Shaw & Co., Inc. | 49,184 | $152.0K |
| Allspring Global Investments Holdings, LLC | 6,107 | $18.9K |
| China Universal Asset Management Co., Ltd. | 1,076 | $3.33K |
| Deutsche Bank AG | 446 | $1.38K |
| Nisa Investment Advisors, LLC | 37 | $114 |
| Daiwa Securities Group Inc. | 104 | $0 |
| Cutler Group LP | 130 | $0 |